There is growing epidemiological and molecular evidence that ABO blood group affects host susceptibility to severe Plasmodium falciparum infection. The high frequency of common ABO alleles means that even modest differences in susceptibility could have a significant impact on the health of people living in malaria endemic regions. We performed an association study, the first to utilize key molecular genetic variation underlying the ABO system, genotyping >9000 individuals across three African populations. Using population-and family-based tests, we demonstrated that alleles producing functional ABO enzymes are associated with greater risk of severe malaria phenotypes (particularly malarial anemia) in comparison with the frameshift deletion underlying blood group O: case -control allelic odds ratio (OR), 1.2; 95% confidence interval (CI), 1.09-1.32; P 5 0.0003; family-studies allelic OR, 1.19; 95% CI, 1.08 -1.32; P 5 0.001; pooled across all studies allelic OR, 1.18; 95% CI, 1.11-1.26; P 5 2 3 10
INTRODUCTION
A link between the ABO blood group system and malaria susceptibility has long been suspected. Significant associations between blood group and Plasmodium falciparum malaria have been reported from cross-sectional and case-control studies in Brazil, Gabon, India, Sri Lanka and Zimbabwe (1 -7) [see also recent reviews and references therein (8, 9) ]. However, other studies in Colombia, India, Sudan and Nigeria could not find an association between malaria and blood group (10 -15) . The positive association studies have consistently suggested that blood group O individuals are relatively protected from severe malaria.
Human erythrocytes infected with mature forms of the P. falciparum parasite adhere to uninfected red blood cells, endothelia and other components of the vascular space (16) . This adhesive behavior is mediated by P. falciparum erythrocyte membrane protein 1 (PfEMP1), which is encoded by a family of highly variant parasite genes and subject to switching during the course of an infection (17) . A range of human host molecules binding to PfEMP1 have been identified including CD36 (18) , intercellular adhesion molecule (ICAM)-1 (19) and complement receptor-1 (CR1) (20) . The ABO A and B antigens have been implicated in the formation of 'rosettes', the process by which infected red blood cells (iRBCs) surround themselves with uninfected erythrocytes (21, 22) . PfEMP1 has been identified as the rosetting ligand of the parasite (20) and the blood group A antigen has been shown to bind to the semiconserved head structure of PfEMP1 (23) . Erythrocyte rosetting is linked to the pathogenesis of severe malaria phenotypes such as cerebral malaria (CM) and severe malarial anemia (SA) (24, 25) . Indeed, fresh isolates of P. falciparum from Kenyan children with severe malaria bind A antigen more frequently than strains from children with mild disease (26) . Recent work on Kenyan and Malian isolates suggests a significant reduction in rosetting in blood group O individuals compared with non-O blood groups. Furthermore, parasites required rosetting activity for blood group O to offer protection from severe disease (27) . Wild and laboratory parasite strains demonstrate blood group preferences, which appear to vary geographically. In general, rosette formation has been shown to occur preferentially with blood group A, B or AB erythrocytes, and particularly, groups A and AB in studies of African strains (21, 22, 28, 29) .
Previous epidemiological studies have employed the phenotype of serology to determine the host ABO genotype. Although convenient, serological studies of the ABO system are unable to discriminate all genotypes, e.g. AO heterozygotes from AA homozygotes, and cannot assess subtler coding or non-coding variation. We took the novel approach of investigating the molecular genetic variation underlying this system. The ABO glycosyltransferase performs the terminal step in the biosynthesis of the ABO macromolecule, adding sugar residues to the precursor H antigen. The enzyme adds either N-acetylgalactosamine, to form the A antigen, galactose to form the B antigen, or is functionless leaving the H (or O) antigen unmodified. A variety of polymorphisms have been reported in the ABO glycosyltransferase gene (30) . The common key functional variants are: (i) a one nucleotide deletion in exon 6 (codon 87) leading to a reading frameshift and premature termination of the polypeptide before the N-terminal catalytic domain, producing the functionless O allele (31) . Alternative 'non-deletional' O alleles exist but are rare in African populations (32) . (ii) Four nonsynonymous single nucleotide polymorphisms (SNPs) (altering residues 176, 235, 266 and 268), which switch enzyme function from A transferase to B transferase activity. The third and fourth SNPs (codons 266 and 268) have the greatest effect on determining the nucleotide-sugar donor used by the transferase, the second amino acid (235) also affects nucleotide -sugar specificity but to a lesser degree, finally the most 5 0 SNP (codon 176) has very little influence on donor specificity (33) .
We designed genotyping assays for the O allele frameshift mutation (rs8176719) and the three key A/B nonsynoymous SNPs in codons 235 (rs8176743), 266 (rs8176746) and 268 (rs8176747) in the catalytic domain. We conducted a multicentred study design employing samples from three African regions: The Gambia (West Africa), Malawi (South Central Africa) and Kenya (East Africa). We used two study types: population-based association studies in each of the regions employing children with severe malarial disease and local cord blood controls and family-based association studies at each site looking for transmission distortion of ABO alleles between parents and affected offspring, an approach that has the advantage of being robust to population stratification. Our aims were: (i) given the presence of substantial linkage disequilibrium (LD) among the functional SNPs in the ABO locus to define the most efficient marker set for large-scale genotyping; (ii) to perform SNP-and haplotype-based tests for association with severe malarial phenotypes; (iii) to employ our family-based genetic data to check for parent-of-origin effects, an approach not possible with previous case-control and cross-sectional study designs and (iv) to consider the population genetic implications of an association between ABO variation and severe falciparum malaria.
RESULTS

Substantial LD between functional SNPs in the ABO glycosyltransferase gene
The four key functional polymorphisms that we tested in the ABO locus are reported to be in substantial LD (30) . To confirm this, we genotyped 1320 Gambian parent-offspring trios, and 30 Yoruba parent -offspring trios from Ibadan in Nigeria [cell line DNA used by International Haplotype Map (HapMap) Project] (34). This allowed us to look at the fine structure of the ABO locus, combining our functional SNPs with the high-density HapMap marker dataset (Fig. 1) .
Genotyping in both sample sets demonstrated near perfect LD (r 2 , 0.9-1.0) among the three nonsynonymous SNPs that distinguish A and B haplotypes. The frameshift deletion underlying O alleles is in moderate LD with the three nonsynonymous SNPs (D 0 , 0.9; r 2 , 0.3). The majority of O alleles occur on an A haplotypic background, although the minority of recombinants with B haplotypes are still expected to produce truncated products. The implication of this haplotypic structure is that two markers, rs8176719 and one of the three nonsynonymous SNPs, can generally distinguish the three ABO alleles.
The common frameshift mutation underlying blood group O is associated with protection from severe malaria phenotypes, particularly SA Two markers, rs8176719 and rs8176746, were genotyped in 3906 cases of severe malaria plus population and family Our analysis took the statistical convention of using the commonest category (i.e. most frequent allele, haplotype or blood group) as reference, and comparing other alleles, haplotypes and inferred blood groups against this category. Single SNP analysis revealed that the minor allele of rs8176719, an insertion relative to the reference sequence (although almost certainly the ancestral allele), is associated with increased risk of severe malaria phenotypes. Consistent trends were found in both family and case-control studies, and across study sites (Table 1 ). However, some individual studies did not reach statistical significance; probably because of lack of power (see Materials and Methods for power calculations). Overall, the case -control allelic odds ratio (OR) was 1.2 and 95% confidence interval (CI) was 1.09 -1.32, P ¼ 0.0003; family studies allelic OR 1.19, 95% CI 1.08-1.32, P ¼ 0.001; pooling data across all our studies, both familyand population-based, suggested an allelic OR of 1.18, 95% CI of 1.11-1.26, P ¼ 2 Â 10 27 for severe disease (Fig. 2) . The results suggest that the full-length allele of rs8176719 may be associated with a particular risk of anemia during severe malaria infections. For the phenotype of SA, the allelic OR and 95% CI were 1.30 and 1.12 -1.5 (P ¼ 0.0004) and 1.34, 1.1-1.64 (P ¼ 0.004) for the case-control and the family-based studies, respectively.
The situation with rs8176746 is more complex. The major allele, although defining the putatively 'high risk' A haplotype, occurs with the 'low-risk' frameshift deletion upstream in about two-thirds of chromosomes. Thus, no simple genetic model is significantly associated with disease when this SNP is considered in isolation. Table 2 ). Trends in the data suggest that blood group B individuals may be at subtly lower risk than blood group A, whereas blood group AB individuals are probably at the greatest risk of severe disease (case -control OR, 1.59; 95% CI, 1.15-2.21 P ¼ 0.006; family OR, 1.46; 95% CI, 1.05 -2.04, P ¼ 0.025).
ABO haplotypes producing
Non-O blood groups demonstrate particularly high risk of SA (e.g. blood group A: case -control OR, 1.54; 95% CI, 1.22-1.96, P ¼ 0.00039; family OR, 1.51, 95% CI, 1.09 -2.09, P ¼ 0.014). The higher risk of SA experienced by individuals with non-O blood groups may reflect a pathophysiological effect, e.g. accelerated clearance of erythrocytes bound to iRBC. Frequencies of genotypes, haplotypes and blood groups for all cases, controls and parents are documented in Supplementary Material, Table S1 .
ABO glycosyltransferase alleles and a possible parent-of-origin effect in disease susceptibility
Previous association studies of the ABO system in severe malaria have examined serological data from unrelated individuals. In this study, having analyzed genetic data from pedigrees, we were in the unique position of being able to look for parent-of-origin effects. We were surprised to find a substantial difference in transmission of high-risk alleles relating to their parent of origin. Full-length alleles of rs8176719 (marking A and B haplotypes) transmitted to offspring are associated with greater risk of severe disease if the allele was transmitted from a mother (OR 1.38, P ¼ 0.0002) rather than a father (OR 1.05, P ¼ 0.6), conditional logistic regression fitting separate effects for maternal and paternal alleles supports the existence of a parent-of-origin effect (x 2 ¼ 3.96, P ¼ 0.047) ( Table 3) .
Interactions between maternal genotype and child's genotype can masquerade as parent of origin effects. To investigate this scenario, we performed a parent-of-origin likelihood ratio test (PO-LRT) of Weinberg (35) , which can allow for maternal genotype effects. The LRT demonstrates evidence of a parent-of-origin effect (P ¼ 0.046), but did not support a maternal genotype effect (P ¼ 0.21) ( Table 4) . Using 2-SNP haplotypes to identify the three ABO alleles, and repeating the conditional logistic regression, we found that both A and B haplotypes are associated with greater risk when transmitted by a mother although only the difference between maternal and paternal A haplotypes is significant (
There was no significant difference in risk estimate for severe malaria between AO and AA genotypes in either the case -control study (AO: OR, 1.35; 95% CI, 1. Low levels of population differentiation at the ABO locus represent a signal of long-standing balancing selection
Given that one ABO allele is protective against a major selection pressure such as P. falciparum malaria, it is important to consider the reasons why the ABO system remains polymorphic in Africa. The answer may relate to the balance of protection offered by the specific ABO alleles to other infectious disease. ABO antigens have been implicated not only in malaria, but also to the pathogenesis of Escherichia coli (36), Helicobacter pylori (37), Norwalk virus (38) , Hepatitis C (39) and respiratory infections (40) . There has also been speculation about whether historical agents such as smallpox and plague may have shaped the global distribution of ABO alleles (41, 42) . 
Blood group A, B and O alleles occur in other primate species. Sequence analysis has suggested that the common ancestral enzyme had A transferase activity and that the presence of species-specific mutations underlying the non-human B and O alleles suggests functional polymorphism of the ABO gene has occurred through convergent evolution (43) . High levels of nucleotide diversity at the ABO locus are considered to be significant evidence of non-neutral evolution in primate lineages.
Surveys for signatures of evolutionary selection in the human genome have demonstrated evidence of balancing selection at the ABO locus (44, 45) . Using our merged haplotype data from the HapMap Yoruba population and our additional genotyping of four functional polymorphisms (rs8176719, rs8176746, rs8176747 and rs8176743), we investigated whether the long-range haplotype (LRH) test (46) , which detects signals of recent positive selection, was associated with the functional ABO variants (Fig. 3) . Neither of our key SNPs appear to be associated with an extended haplotype homozygosity signal, which is consistent with a long-standing process of balancing selection. A recently reported high LRH score from the ABO locus (45) may reflect positive selection of nearby regulatory sequence controlling expression patterns rather than coding sequence itself. Interestingly, we observed very low levels of population differentiation across the ABO locus in HapMap populations (Fig. 4A) . The ABO locus including sequences 20-30 kb upstream, a region of 85 SNPs, has an F ST (using a sample-size weighted metric of population differentiation among African, Asian and European populations) of 20.001, compared with a genome-wide average of 0.1. Although more attention is generally given to high F ST values, as signals of region-specific positive selection [e.g. the Duffy blood group locus under selection in Africa from P. vivax malaria (47)], here the low F ST might reflect simultaneous balancing selection in all three populations, and would be consistent with a model of long-standing selection. The extension of the low F ST region 20-30 kb upstream of the ABO coding sequence (while stopping just 3 kb downstream) may indicate that the balancing selection is also shaping the cis-acting regulatory sequences immediately upstream of the gene. Although not a formal test of deviation from neutrality, we measured the empirical distribution of F ST in windows across chromosome 9 and found the ABO region to be around the 99.5 -99.9th centile in this distribution (Fig. 4B) .
DISCUSSION
Our analysis strongly supports the hypothesis that blood group O individuals are relatively protected from severe malaria in comparison with other blood groups, particularly blood group A and AB. In addition to population-based studies, we conducted the first family-based association studies of ABO variation, with severe malaria. The analysis of parentoffspring trios is robust to artifacts of population stratification and allowed us to examine the possibility of parent-of-origin effects. We found that full-length alleles at rs8176719, particularly A haplotypes, inherited from a mother lead to greater risk for offspring than similar alleles inherited from a father. The analysis suggests a phenomenon such as genomic imprinting rather than an effect of maternal genotype. The tissue-and cell-type specific expression of ABO is controlled by epigenetic signals, particularly at a 5 0 CpG island in the promoter of the gene (48) . The loss of ABO expression mediated by promoter hypermethylation is common in certain forms of malignancy (49) . There has also been a small case series documenting preferential loss of the maternally derived ABO allele in adult leukemia (50) . Our results would be consistent with altered expression of the paternal ABO allele because of imprinting, leaving less target ligand for iRBCs to bind to, or shifting the pattern of sequestration to a 'safer' distribution. Paternal allele expression is not abolished, as demonstrated by the existence of blood group AB. However, it is interesting to speculate that during gestation it could be beneficial to modulate or suppress the paternal ABO allele, so as to minimize maternal -fetal ABO incompatibility and the risk of hemolytic disease of the newborn. To our knowledge, this is the first report suggestive of genomic imprinting in the genetics of malaria susceptibility. However, despite our sample size, we have limited power to detect the subtle difference in risk between maternal and paternally derived alleles, it remains possible that this suggestive result is in fact type I error. Further experiments are required to confirm this finding, and could include family-based studies of ABO variation in malaria and other complex diseases, or functional experiments with family-derived samples to determine whether ABO gene expression is affected by parent of origin.
The sizes of our individual study datasets give us limited power to analyze the differences between regions. The differences in OR between a family study and a case -control study in a single population are of similar magnitude to the Figure 2 . Estimated risk for ABO rs8176719 in severe malaria. For each study, the figure represents the estimated ORs (circular marks) and 95% CI (horizontal lines) for the full-length allele, in severe malaria. P-values were derived from regression analysis with covariates of ethnic group, gender and HbS genotype (for population-based studies), case-pseudo-control approach (for family studies) or UNPHASED analysis (pooled data across all studies). The interrupted lines represent the CI of the pooled data for all studies, both family and population based, using the UNPHASED application.
differences seen between regions, suggesting much of the variation observed is because of statistical fluctuation or methodological issues. Factors possibly contributing to the diversity of risk estimates reported between our populations, and in comparison with other reports include variation in phenotype definition and geographic differences in parasite strain, e.g. differing affinities for ABO antigens. The use of cord blood controls instead of age-matched controls could affect 
association results. Cord blood samples represent the distribution of genotypes in the populations at birth; since a minority will go on to develop severe disease, this will tend to underestimate the true OR of any genetic susceptibility or resistance allele. In contrast, if blood group O individuals are depleted from the population between birth and midchildhood (the age of the cases) because of non-malarial pathogens, this would lead to an over-estimation of protection from blood group O. However, given the consistent results between the population-and family-based studies, the similar allele frequencies between cord blood samples and untransmitted parental alleles and the limited effect size found, such biases are probably limited. Our study employed samples from children with severe malaria phenotypes and it has been noted that the ABO effect is harder to detect in samples incorporating adults with malaria (8) . The gradual accumulation of antibodies against a range of iRBC surface antigens is thought to explain a component of the immunity to severe lifethreatening malaria that develops in late childhood in endemic regions (51) . It is possible that a limited repertoire of parasite epitopes binding A and B antigens could lead to a high prevalence of effective antibodies against these variants in adults, reducing the significance of host ABO blood group in older age groups. It is interesting to speculate whether vaccination, leading to effective immunity to A and B antigen binding PfEMP1 variants, could reduce morbidity among blood group A, B and AB children.
The modest effect size found is typical of validated associations with complex disease in humans. The effect size is likely, in part, to explain why some previous studies have been unable to demonstrate significant results, despite trending toward protection from blood group O, particularly when sample size was low. However, the global health impact of the frameshift deletion, underlying blood group O, needs to be put in context by considering its high frequency. Roughly half the peoples of Sub-Saharan Africa, and many other human populations, at risk of life-threatening disease caused by P. falciparum, are homozygotes for this null mutation and are protected by being blood group O (52).
MATERIALS AND METHODS
Subjects
Patient samples were collected as part of ongoing epidemiological studies of severe malaria at the Royal Victoria Hospital, Banjul, The Gambia; the Queen Elizabeth Central Hospital, Blantyre, Malawi and Kilifi District Hospital, Kilifi, Kenya. Populations in these study sites are exposed to endemic malaria, with the burden of life-threatening disease being experienced by children (,5 years old). Nuclear family trios comprised two parents and one affected child. All DNA samples were collected and genotyped following approval from the relevant research ethics committees and informed consent from participants. Controls were cord blood samples obtained from birth clinics in the same locality as the cases. See Supplementary Material, Table S2 for further demographics of patients and controls.
Phenotype definition
All cases were children admitted to hospital with evidence of P. falciparum on blood film and clinical features of severe malaria (53, 54) . In our analyses of sub-phenotypes, we use Blantyre coma score of 2 as a criterion of CM, and hemoglobin ,5 g/dl or packed cell volume ,15% as a criterion of SA. Some individuals had both CM and SA. Of the severe malaria cases that were not CM or SA by these criteria, most had lesser degrees of coma (Blantyre coma score 3) or , log ratio test x 2 value; df, degrees of freedom, P-value, P-value for the likelihood ratio test; PO, parent-of-origin effect included in model. 
Power calculations
Power calculations were performed using the Genetic Power Calculator (http://pngu.mgh.harvard.edu/~purcell/gpc) (55) . A single regional case -control study had 61% power, based on a sample size of 700 cases, 700 unselected controls, allelic OR of 1.2 (our risk estimate for non-O alleles compared with O alleles), high-risk allele frequency of 0.3 and a type I error rate of 0.05. Across all case -control studies, we would expect 97% power. The smaller family trio studies (n ¼ 230 trios) had 25% power, whereas the larger Gambian study (n ¼ 1320 trios) had 87% power.
Sample preparation and genotyping
Genomic DNA samples underwent whole-genome amplification through either primer extension pre-amplification (PEP) (56) or multiple displacement amplification (MDA) (57), before genotyping on a Sequenom MassArray genotyping platform (58) . All assays achieved high rates of genotyping success and no deviations from Hardy -Weinberg equilibrium were encountered (Supplementary Material, Table S2 ).
Statistical analysis
Analysis was performed using STATA (v9.2 for windows) and the genassoc package (http://www-gene.cimr.cam.ac.uk/ clayton/software/) written for STATA by David Clayton. In general, the results for the multiplicative model are presented. Although full-length alleles are dominant with regard to blood group phenotype, we found a trend toward increased susceptibility for blood group AB individuals (homozygotes for the full-length allele at rs8176719), which makes this model valid. Case -control association analysis was undertaken by logistic regression and included the covariates of ethnic group, gender and Sickle status. DNA Sequenom genotyping for the Hemoglobin S (HbS) variant was performed for all samples. The HbS results for a proportion of the Gambian samples have been published previously (59) . Gender was included in the regression analysis to control for sex-linked traits (e.g. G6PD). With regards to other variation thought to affect malaria susceptibility, Hemoglobin C was absent from our study populations and the range of deletions underlying the Thalassemias are not easily amenable to the highthroughput genotyping technology used.
The family-based association analysis was performed using a case -pseudo-control approach and conditional logistic regression (60) . Trios were drawn from a larger pool of samples checked for relationship misspecification. All family samples were genotyped for 48 SNP markers and 15% of trios (indicated by their Mendelian errors rates) excluded from further analysis.
In the population-based studies, two SNP haplotypes (and therefore the ABO alleles) were reconstructed using the snp2hap function, whereas in family studies, phase can often be tracked from parent and child in the creation of the case-pseudo-control dataset. Data from the case-control studies were pooled in a single logistic regression analysis including covariates of ethnic group, gender and Sickle status, whereas family studies were combined in a single case-pseudo-control analysis. Pooling across all casecontrol and family studies is less straightforward. Here, we used the UNPHASED application version 3.0 (http:// www.mrc-bsu.cam.ac.uk/personal/frank/software/unphased/) (61, 62) , which employs a retrospective likelihood framework for performing genetic association analysis, and can be used to combine data from nuclear families and unrelated subjects. Ethnic origin was found to be a significant confounder and was retained as a covariate in the UNPHASED analysis.
Integrating phased genotypes from the HapMap project
Phased ABO locus haplotypes for the 30 Yoruba parent -offspring trios from Ibadan in Nigeria were downloaded from the HapMap website (http://www.hapmap.org) (34) . Cell lines derived from the Yoruba individuals (obtained from the Three different window sizes were used based on either marker numbers (85 SNPs), genetic distance (0.054 cM) or physical distance (50 kb), only windows containing more than two markers were included. By all three distributions, the region around the ABO locus is a relative outlier 99.5-99.9th centile for low F ST .
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Coriell Cell Repositories, http://ccr.coriell.org/) were genotyped for the four key SNPs. The additional SNP data was combined with the known phased genotypes using PHASE version 2.1 (63, 64) . LD patterns between our genotyped SNPs and between these genotypes and HapMap markers were visualized using HAPLOVIEW, version 3.32 (http:// www.broad.mit.edu/mpg/haploview/) (65) . Extended haplotype homozygosity values (46) were calculated using SWEEP, version 1.0 (http://www.broad.mit.edu/mpg/sweep/ index.html).
F st calculation and window-based screen of chromosome 9
Single nucleotide polymorphism genotyping data for chromosome 9 was downloaded from the HapMap website (Release 21a/Phase 2, Jan 2007). The dataset was derived from three populations: the 30 Yoruba trios; 30 US parent -offspring trios of northern and western European origin, collected by the Centre d'Etude du Polymorphisme Humain (CEPH); and a combined dataset of 45 unrelated individuals from the Tokyo, Japan and 45 unrelated individuals from Beijing, in China (34) . A total of 94 678 SNPs across chromosome 9 were polymorphic in all three populations. The F ST among the three populations was estimated, in windows across chromosome 9, using the formula for F ST described in the supplementary information to the HapMap Consortial publication (34) .
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online. 
